Target intelligence / Profile preview

Central appetite regulatory network

Molecular classification
G protein-coupled receptor, Ion channel, Neurotransmitter transporter, Transcription factor
01

Overview

The central appetite regulatory network is a complex, multi-regional anatomical system primarily centered in the hypothalamus and the hindbrain that integrates peripheral and central signals to maintain energy homeostasis. Within the hypothalamus, the arcuate nucleus (ARC) serves as a primary hub, containing pro-opiomelanocortin (POMC) neurons that signal satiety and Agouti-related peptide (AgRP)/Neuropeptide Y (NPY) neurons that stimulate hunger [1][2]. The hindbrain, specifically the nucleus tractus solitarius (NTS), receives vagal afferent signals regarding gastric distension and gut peptide release (e.g., CCK, GLP-1) to coordinate short-term meal termination [3]. Additionally, the mesolimbic reward system, including the ventral tegmental area (VTA) and nucleus accumbens, modulates hedonic feeding by processing the palatability and incentive value of food [4]. Dysregulation of these circuits—often through leptin resistance or altered sensitivity to satiety hormones—is a fundamental driver of obesity and various eating disorders [5]. Modern pharmacological interventions, such as GLP-1 receptor agonists and MC4 receptor agonists, specifically target these regions to suppress appetite and promote weight loss [6].

Other names
Brain regions involved in appetite controlHypothalamic-hindbrain appetite axisAppetite regulatory circuitFeeding centers
02

Mechanism of action

Modulation of hunger and satiety signaling through G protein-coupled receptor agonism (GLP-1R, MC4R), sympathomimetic amine release, and opioid receptor antagonism within hypothalamic and reward-based neurocircuits.

03

Biological functions

Energy homeostasisSatiety signalingReward processingMetabolic regulationNutrient sensing
04

Disease associations

ObesityAnorexia nervosaBinge eating disorderMetabolic syndromeBulimia nervosaCachexia
05

Safety considerations

Gastrointestinal adverse effects (nausea, vomiting)Neuropsychiatric risks (anxiety, depression, suicidal ideation)Increased heart rate and blood pressureRisk of pancreatitisPotential risk of thyroid C-cell tumors
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

Body Mass Index (BMI)Plasma leptin concentrationPlasma ghrelin concentrationHemoglobin A1c (HbA1c)Resting energy expenditure (REE)

Beyond the preview

Go deeper on Central appetite regulatory network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central appetite regulatory network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call